Why Omicron spreads so fast? High viral load in the nose? No. Immune escape? Yes. (and apparently short incubation period and loads of a/presymptomatic people) nature.com/articles/d4158…

Tilanne Ukrainassa on huolestuttava ja liikkeellä on paljon virheellistä tietoa. Toimittaja: jos teet juttuja aiheesta, Venäjän tutkijamme auttavat mielellään tulkinnoissa! 🤝 #Ukraina #Putin #Venäjä #asiantuntijalista #WeAreHelsinkiUni Soittele! 👇📞 helsinki.fi/fi/ajankohtais…

Lääkeyritykset kuskaavat valmistuneet rokotteet sinne, missä on rahaa. "Kysymys ei ole patenteista vaan ihmisten välisestä solidaarisuudesta", lataa virologian professori Kalle Saksela Yliopisto-lehti jutussa. helsinki.fi/fi/uutiset/pan…

Happy and Peaceful Easter! During the long weekend and vigorous egg hunt, I would like to invite you to take a tour of Pandemblock Oy´s website pandemblock.com & get introduced to our mission. #pandemblock #pandemicpreparedness #antiviral #intranasal #protection #sherpabody

Take a look at our innovative antiviral approach tackling respiratory virus infections using propiertary Sherpabody-binder protein technology. pandemblock.com #pandemblock #pandemicpreparedness #intranasal #antiviral #protection #sherpabody

"SARS-CoV-2 is rapidly mutating and recombining, and more (sub)variants—potentially more pathogenic—are on the horizon. The world is still barely vaccinated, and even in wealthy countries like the US, resources are inequitably distributed. It ain't over." science.org/doi/10.1126/sc…

The answer blocking #SARSCoV2 may be up in the nose - nasal vaccines and antiviral inhibitors. #covid19 #pandemic #ptotection #nasalvaccine #nasalinhibitor theguardian.com/commentisfree/…

The #SARSCoV2🦠has been relentlessly evolving over the past 3 years to find new hosts. Its latest iteration, XBB.1.5, acquired a critical double mutation that maintains high level of immune escape while increasing infectivity by Yunlong Richard Cao and colleagues biorxiv.org/content/10.110…

Tutkijat University of Helsinki ovat kehittäneet molekyylin, joka nenään annosteltuna estää erittäin tehokkaasti koronaviruksen aiheuttaman taudin. Molekyyli toimii myös uusimpia immuunipuolustusta kiertäviä virusmuunnoksia vastaan. #HyvätUutiset Anna R. Mäkelä, PhD helsinki.fi/fi/uutiset/pan…

Researchers University of Helsinki have developed a molecule that is, when administered nasally, extremely effective in preventing the disease caused by all known variants of the SARS-CoV-2 virus. The molecule could be a key tool in preparing for future pandemics. 💪helsinki.fi/en/news/pandem…

In the lab: A nasal spray developed in Finland protects against #SARSCoV2 infection, including recent immune-evasive variants. When administered nasally the experimental molecule—TriSb92—developed at Univ of Helsinki blocks transmission & spread of #SARS2 nature.com/articles/s4146…

JUST OUT: #Intranasal highly stable trimeric #sherpabody inhibits #SARSCoV2 including recent immunoevasive Omicron subvariants - effective likely against future VOCs. #TriSb92 #antiviral #nasalspray #covid19 #pandemblock Nature Communications Pandemblock Oy nature.com/articles/s4146…

A paper in Nature Communications describes a small antibody-like protein that can prevent infection by diverse SARS-CoV-2 variants in cell culture and in mice that were intranasally treated with this inhibitor before or shortly after being exposed to the virus. go.nature.com/40ovTFm

Finnish Researchers Develop Nasal Spray That Protects against #COVID Researchers have developed a molecule for nasal administration to prevent development of #COVID19 symptoms by all known variants of the #SARSCoV2 virus. Learn more: ow.ly/w4M550NtRS3

An antiviral therapy in early development has the potential to prevent or treat COVID-19 infection when given as a nasal spray in as little as 4 hours before or after exposure. wb.md/3U2oRnG

Could A Nasal Spray Be Your Next Line Of Defense Against COVID? healthdigest.com/1246915/could-…

Tänään juhlistetaan maailman luovuuden ja innovaation päivää! 💡United Nations Tutkijamme ovat kehittäneet molekyylin, joka voi olla ratkaiseva ase varautumisessa tuleviin pandemioihin. Se estää nenään annosteltuna tehokkaasti kaikkien tunnettujen koronavirusmuunnosten aiheuttaman taudin.

Researchers have developed a molecule that is, when administered nasally, extremely effective in preventing the infection of all known variants of the SARS-CoV-2 virus. The sherpabody-technology used can be a key tool in preparing for future pandemics. ➡️ helsinki.fi/en/news/pandem…

Excited to share our latest work! 🚀 We introduce sherpabodies, a modular, antibody-mimetic platform for CAR-T cell therapy targeting solid tumors. 🧫🔬🧬 Collaboration betweem the Saksela Lab University of Helsinki and Cell Design Institute @UCSF Check it out here: 🔗 aacrjournals.org/cancerres/arti…

Our #sherpabody technology offers precision in targeting cancer cell therapies and efficiency in combating viral infections. Our latest research on #CARTcell therapy has just been published in Cancer Research. helsinki.fi/fi/uutiset/syo… #cancertherapy